IPJur: Pharmaceutical Sector: EC Competition Rules ./. Patent System?
Forum » Resources / News picks » IPJur: Pharmaceutical Sector: EC Competition Rules ./. Patent System?
Started by: zoobabzoobab
Date: 03 Dec 2008 14:07
Number of posts: 1
rss icon RSS: New posts
Summary:
Generic companies and originator companies are in agreement over the need for a single Community patent and the creation of a unified and specialised patent judiciary in Europe. A significant number of generic companies - and to some extent also originator companies - call upon the EPO to ensure that patents granted are of high quality and to effectively counter patent strategies that may result in unnecessary delays. The inquiry suggests that significant cost and efficiency improvements could be achieved by creating a Community patent and a unified patent judiciary (e.g. by avoiding the high number of essentially parallel court cases, divergent outcomes of cases and the costs associated with multiple national patents and national patent litigation).
New Post